Frequent exacerbations in COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
Tiotropium: COPD exacerbations and decline in FEV1 Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Frequent exacerbations in ex smokers with COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2005; 26: Suppl. 49, 510s Year: 2005
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Cardiac disease from accelerated FEV1 decline and acute exacerbations: time to rethink comorbidities in COPD Source: Eur Respir J, 57 (3) 2004008; 10.1183/13993003.04008-2020 Year: 2021
Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013
Changes in FEV1 and SpO2 in patients with severe and very severe COPD Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Decline of FEV1 in different groups of severe refractory asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 575s Year: 2005
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016
Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014
Acute exacerbation is not related to the decline of airway calibre in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 184s Year: 2001
Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015
Predictors of frequent hospitalisations for exacerbations in COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020
Predictors of exacerbations of COPD Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Exacerbation frequency and FEV1 decline of COPD: is it geographic? Source: Eur Respir J 2014; 43: 1220-1222 Year: 2014
Cough in exacerbations of COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008